4-Nitro-3-(trifluoromethyl)benzaldehyde, 95.0%, 25g

OCT Embedding Matrix, 375 ml, 3 x 125 ml

8-[(oxiran-2-yl)methyl]-1,4-dioxa-8-azaspiro[4.5]decane, 95.0%, 10g

Lacmoid, pa, 100 g, glass packaging

3-Chloro-2,4,5,6-tetrafluoropyridine>98.0%(GC)5g

2,3-Bis(chloromethyl)pyridine hydrochloride, 97%, 1g

4,6-Dimethylpyrimidine-2-carbonitrile, 98.0%, 5g

Tris(1,10-phenanthroline)cobalt(III) Tris(hexafluorophosphate)>97.0%(T)5g

5-BROMO-1,2,3-TRIAZOLO[1,5-A]PYRIDINE, 97.0%, 100mg

2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide, 98%, 5mg

2-(4-Hydroxy-phenyl)-N-phenyl-acetamide, 97.0%, 25g

Methyl 3,3-difluorocyclobutanecarboxylate, 95.0%, 1g

Diphenyl-2-pyridylphosphine, 97.0%, 25g